Plain-English translation of NCT07262762 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is evaluating how well Spartina (tirzepatide) works for weight loss and whether it is safe to use in people who are overweight or have obesity. All participants will receive this medication, and researchers will carefully track how much weight you lose and monitor you for any side effects or safety concerns.
While this medication has been approved and is available to patients, this real-world study aims to understand how well this treatment works and how safe it is in everyday clinical practice outside of controlled research settings.
You likely qualify if…
You likely don't qualify if…
You will receive the medication as part of your regular treatment for weight loss. Researchers will monitor your progress by measuring your weight, checking your safety through physical exams and blood tests, and asking about any side effects you experience. The study does not include a comparison group—everyone receives the same treatment—and the exact schedule of visits and study duration will be determined by your healthcare provider.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
Iran